• HOME
  • SPECIALTIES
    • Surgical
    • Therapeutic
    • Cardiovascular
    • Orthopedic
    • Ophthalmology
    • Urology
    • Dental
    • Radiology
    • IVD
    • Drugs
  • REGULATORY
    • Quality System
    • Standards
    • Design Control
    • Risk Management
    • System Modeling
    • Requirements
    • Design Description
    • Unit Tests
    • Verification
    • Validation
    • Traceability
    • Automated V&V
  • ENGINEERING
    • Algorithms
    • Software
    • Electronics
    • Optics
    • Mechanics
    • Fluidics
    • Design
    • Production
    • Systems
  • NEWS
    • 2025 NEWS
    • 2024 NEWS
    • 2023 NEWS
    • 2022 NEWS
    • 2021 NEWS
SPECIALTIES
surgical
therapeutic
cardiovascular
orthopedic
ophthalmology
urology
dental
radiology
IVD
DRUGS
  • Surgical

  • Therapeutic

  • Cardiovascular

  • Orthopedic

  • Ophthalmology

  • Urology

  • Dental

  • Radiology

  • In Vitro Diagnostics

  • Drug Delivery

Design and development of medical devices is a major area of focus for Syprosoft® Engineering. We have worked on products covering nearly all of the medical specialties. For details, click on the buttons shown.

MEDICAL DEVICE Regulations

Medical devices are regulated by the FDA based on patient risk. The higher the risk the greater the mandates. Class I devices need to comply with general controls including registration, listing, labelling & good manufacturing practices. Class II devices are subject to special controls including performance, guidelines, pre-market data and surveillance. Class III devices require pre-market approval (PMA) by the FDA.
Regulatory clearance is obtaining permission for new product sales. Syprosoft® Engineering guides clients in navigating the clearance pathway. For high risk devices a cumbersome PMA may be needed. At the other end, some devices are exempt from any filing. The majority fall in between. If the client’s device can be shown to be “substantially equivalent” to a previously cleared device (“predicate”) then a relatively simple traditional 510(k) pathway applies. If no predicate exists a more complex de novo pathway applies. Note that “substantially equivalent” is not the same as “significantly equal”. This is an opportunity to diminish the claims for the new product to make it substantially equivalent to a predicate. Once clearance is obtained the client may be able to use its own product as a predicate to expand the claims via a special 510(k).
Regulatory compliance is adherence to an quality system. For new products, this includes planning, risk management, requirements, specifications, design descriptions, design output, verification and validation. Syprosoft® Engineering helps clients comply with the latest regulations. We put together systems that are customized to the client’s operations and add only minimal burdens. We design processes that are not only compliant with the regulations but also appropriate to the size of the client thus minimizing compliance costs.
back
next
HOME
SPECIALTIES
REGULATORY
ENGINEERING
news
We Do What We Promise
Contact: Dipu Ghosh, President dghosh@syprosoft.com IN dipughosh
Syprosoft Inc. www.syprosoft.com IN syprosoft-engineering
Syprosoft®, SyproPLAN™ and ●●●RAPID® are trademarks of Syprosoft, Inc. Copyright © 2026 Syprosoft, Inc. All rights reserved. Use of this website is at your own risk, and Syprosoft Inc. is not liable for any damages arising from its use.

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Cookies and Privacy Policy.

Your Cookie Settings

We use cookies to enable essential functionality on our website and analyze website traffic. For more information, read our Cookies and Privacy Policy below..

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites.

Analytics

These cookies collect information that is used in aggregate and in an anonymized form to help us understand how our website is being used and how effectively our site is performing.